Literature DB >> 26719032

Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells.

Hye Young Choi1, Nammi Park2, Jae Boem Na1, Eun Sook Ko3, Jae-Yong Park4, Jae Cheal Yoo4.   

Abstract

Copine3, a known calcium-dependent membrane binding protein, contains two tandem C2 domains and an A domain. This protein has been shown to interact with receptor tyrosine kinase 2 (ErbB2), but little is known concerning the physiological function of Copine3. To better understand its cellular function, we carried out a yeast two-hybrid screen to find Copine3 binding partners. Among the identified proteins, Jun activation domain-binding protein 1 (Jab1) appears to directly interact with Copine3. This physical interaction between Copine3 and Jab1 as well as the specific binding regions of both proteins were confirmed in vitro and in vivo. Our results also demonstrate that binding of Copine3 to ErbB2 is increased when Jab1 is overexpressed in SKBr3 breast cancer cells. Furthermore, two ErbB2 downstream signaling proteins [phosphatidylinositol 3 (PI3) kinase and protein kinase B (AKT)] were also activated by Jab1 overexpression in these cells. These data suggest that binding of Copine3 and Jab1 regulates, at least to some extent, the ErbB2 signaling pathway. Moreover, overexpression of both Copine3 and Jab1 in SKBr3 cells effectively increased cellular migration. Collectively, our findings indicating that Jab1 enhances the ErbB2 binding ability of Copine3, further activating the ErbB2 signaling pathways involved in breast cancer cell pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26719032     DOI: 10.3892/or.2015.4472

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Upregulation of CPNE3 suppresses invasion, migration and proliferation of glioblastoma cells through FAK pathway inactivation.

Authors:  Dijian Shi; Bo Lin; Jun Lai; Kaipeng Li; Yimo Feng
Journal:  J Mol Histol       Date:  2021-03-16       Impact factor: 2.611

2.  CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer.

Authors:  Haicheng Tang; Jianjie Zhu; Wenwen Du; Shunlin Liu; Yuanyuan Zeng; Zongli Ding; Yang Zhang; Xueting Wang; Zeyi Liu; Jianan Huang
Journal:  J Exp Clin Cancer Res       Date:  2018-07-03

3.  Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib.

Authors:  Zhuo Chen; Zhengkui Jiang; Wenzhou Zhang; Baoxia He
Journal:  Cancer Manag Res       Date:  2018-08-29       Impact factor: 3.989

4.  CPNE3 regulates the cell proliferation and apoptosis in human Glioblastoma via the activation of PI3K/AKT signaling pathway.

Authors:  Dainan Zhang; Xiaoyin Wang; Xi Wang; Zemin Wang; Shunchang Ma; Chuanbao Zhang; Shaomin Li; Wang Jia
Journal:  J Cancer       Date:  2021-10-28       Impact factor: 4.207

5.  CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.

Authors:  Jiabei Liang; Jian Zhang; Jun Ruan; Yuanyuan Mi; Qiang Hu; Zhirong Wang; Bingbing Wei
Journal:  Med Sci Monit       Date:  2017-11-19

6.  High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia.

Authors:  Lin Fu; Huaping Fu; Jianlin Qiao; Yifan Pang; Keman Xu; Lei Zhou; Qingyun Wu; Zhenyu Li; Xiaoyan Ke; Kailin Xu; Jinlong Shi
Journal:  Cancer Sci       Date:  2017-08-20       Impact factor: 6.716

7.  High expression of Copine 1 promotes cell growth and metastasis in human lung adenocarcinoma.

Authors:  Shunlin Liu; Haicheng Tang; Jianjie Zhu; Heguo Ding; Yuanyuan Zeng; Wenwen Du; Zongli Ding; Pengtao Song; Yang Zhang; Zeyi Liu; Jian-An Huang
Journal:  Int J Oncol       Date:  2018-09-12       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.